Lemaitre vascular inc (LMAT)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating activities
Net income

17,595

17,934

19,346

18,476

22,603

22,943

21,202

21,930

17,811

17,177

15,490

13,677

11,643

10,590

10,523

9,386

8,555

7,758

7,144

5,986

5,491

3,915

2,745

2,532

2,149

3,202

3,154

3,096

3,031

2,571

2,219

2,770

2,465

2,143

0

0

0

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

5,670

5,416

5,191

4,852

4,572

4,324

4,197

4,195

4,112

4,055

3,899

3,741

3,689

3,591

3,555

3,534

3,443

3,394

3,409

3,386

3,335

3,334

3,241

3,162

3,014

2,793

2,575

2,380

2,296

2,234

2,204

2,192

2,124

2,037

0

0

0

Stock-based compensation

2,675

2,642

2,650

2,532

2,474

2,349

2,205

2,554

2,390

2,256

2,330

1,977

1,837

1,680

1,531

1,477

1,426

1,424

1,408

1,368

1,352

1,302

1,268

1,241

1,254

1,253

1,244

1,238

1,227

1,213

1,186

1,097

1,097

1,097

0

0

0

Fair value adjustment to contingent consideration obligations

191

171

118

8

-15

-29

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

83

0

0

0

Provision for doubtful accounts

338

388

344

337

312

264

287

272

255

230

205

161

101

105

78

174

182

182

179

86

75

54

53

60

-1

-29

-38

-1

145

153

98

13

-36

56

0

0

0

Provision for inventory write-downs

705

747

881

903

808

671

422

382

360

396

354

347

463

362

280

351

359

462

621

570

731

667

572

455

451

479

331

595

505

863

1,186

1,146

1,226

1,011

0

0

0

Provision (benefit) for deferred income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Excess tax benefits from stock-based compensation awards

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

225

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Non cash restructuring charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-732

0

0

0

Foreign currency transaction loss

-205

57

-195

-100

-211

-259

-131

-87

-16

29

-26

-44

-4

-59

31

-108

-85

-100

-188

-24

-74

-60

-34

-36

-67

-115

-166

-195

-202

-369

-308

-337

-264

156

0

0

0

Changes in operating assets and liabilities:
Accounts receivable

1,699

1,301

2,567

793

1,824

1,283

-95

992

78

1,507

904

1,213

955

922

869

806

1,048

1,879

1,538

1,690

2,378

654

1,504

1,363

733

1,247

476

899

999

640

-147

224

-507

174

0

0

0

Inventory and other deferred costs

10,826

11,335

10,777

8,244

5,824

4,262

3,083

1,891

1,058

1,352

1,248

1,165

844

134

-425

-521

-611

-608

256

220

2,109

2,711

2,713

2,987

2,546

2,168

2,590

3,151

3,607

3,725

4,140

3,333

944

998

0

0

0

Prepaid expenses and other assets

-266

654

-897

-271

1,039

418

649

-494

-88

288

-515

-506

-685

-1,528

1,634

1,217

1,043

2,035

-165

86

-325

-553

384

363

125

236

15

-93

-229

-303

-340

-271

-243

-105

0

0

0

Accounts payable and other liabilities

-357

-596

2,628

302

2,884

4,314

392

1,992

-166

1,524

-515

229

1,328

-103

3,602

2,153

1,919

2,617

-568

-256

-397

-1,086

284

214

174

861

36

377

941

1,357

-704

-230

-1,407

-3,170

0

0

0

Net cash provided by (used in) operating activities

15,587

14,179

15,156

14,994

15,536

19,506

19,705

23,595

24,143

22,868

20,292

18,444

18,114

16,896

16,627

14,488

13,296

11,438

10,195

8,880

6,601

5,512

4,186

3,681

4,045

5,388

4,459

3,932

3,990

4,722

3,992

4,503

5,970

3,170

0

0

0

Purchases of property and equipment and other assets

3,822

3,761

3,651

3,475

3,429

3,054

3,401

5,203

5,153

6,417

5,791

4,021

3,812

2,841

2,545

2,744

2,670

2,273

1,958

1,418

1,064

1,174

1,069

1,224

2,490

2,733

2,859

2,683

1,614

1,209

1,405

1,851

1,777

2,021

0

0

0

Purchases of short-term marketable securities

13,848

22,699

22,049

22,037

30,479

19,619

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sales of short-term marketable securities

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments related to acquisitions

0

-

-

-

-

-

-

-

-

-

-

-

-

14,368

2,507

2,665

3,809

1,565

2,408

7,634

6,504

6,559

5,577

3,373

3,373

3,291

0

0

0

-

-

-

-

1,151

0

0

0

Proceeds from divestitures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

500

253

1,441

1,412

1,414

0

0

0

Purchase of intellectual property

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15

32

51

169

164

147

168

79

116

0

0

0

-

-

-

-

Purchase of technology and licenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Net cash used in investing activities

-12,369

-24,100

-19,297

-17,294

-18,290

-7,055

-32,490

-31,101

-27,788

-28,958

-17,793

-16,023

-15,800

-17,211

-5,063

-5,066

-6,121

-3,480

-4,003

-9,045

-7,570

-7,748

-6,678

-4,648

-6,032

-6,188

-10,401

-6,970

-5,681

-5,198

-1,808

-1,026

-1,335

-1,822

0

0

0

Financing activities
Payments of deferred acquisition consideration

-

2,059

87

116

1,197

1,199

1,207

1,217

238

463

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock

4,632

4,856

3,298

3,239

3,134

2,969

2,839

3,937

4,973

5,500

5,528

3,073

2,120

1,442

2,502

4,448

4,652

4,836

3,718

1,210

11,063

10,834

11,354

11,710

1,145

1,219

0

0

0

-

-

-

-

69

0

0

0

Purchase of treasury stock

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

266

266

210

216

211

250

277

284

373

370

1,014

1,509

2,021

2,739

2,801

2,439

2,213

0

0

0

Common stock cash dividend paid

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,845

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Excess tax benefits from stock-based compensation awards

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

225

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) financing activities

-6,787

-4,622

-3,705

-3,721

-4,249

-4,416

-4,179

-2,881

-222

80

104

-1,701

-2,159

-2,577

-688

404

1,601

1,079

-558

-3,301

6,158

6,662

7,500

9,475

-918

-961

-1,070

-2,142

-2,475

-3,157

-4,572

-4,553

-4,042

-3,800

0

0

0

Effect of exchange rate changes on cash and cash equivalents

-253

11

-539

-353

-1,012

-813

-446

-95

838

818

261

85

-286

-271

145

59

140

-278

-359

-616

-668

-445

-280

94

107

24

-1

-72

-154

-51

-60

-167

-74

-30

0

0

0

Net increase (decrease) in cash and cash equivalents

-3,822

-14,532

-8,385

-6,374

-8,015

7,222

-17,410

-10,482

-3,029

-5,192

2,864

805

-131

-3,163

11,021

9,885

8,916

8,759

5,275

-4,082

4,521

3,981

4,728

8,602

-2,798

-1,737

-7,013

-5,252

-4,320

-3,684

-2,448

-1,243

519

-2,482

0

0

0

Supplemental disclosures of cash flow information (see Note 12)